Regulation of IL-10 gene expression in Th2 cells by Jun proteins

被引:126
作者
Wang, ZY
Sato, H
Kusam, S
Sehra, S
Toney, LM
Dent, AL
机构
[1] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[3] Walther Canc Inst, Indianapolis, IN 46208 USA
关键词
D O I
10.4049/jimmunol.174.4.2098
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-10 is a key regulatory cytokine produced by T lymphocytes. Although Th2 cells are a major source of IL-10, little is known about IL-10 gene regulation in Th2 cells. High levels of IL-10 mRNA transcription are induced in the Th2 clone D10 after PMA plus ionomycin (P/I) stimulation; however we found that the IL-10 promoter was not inducible by P/I in D10 cells. We therefore sought regulatory regions in the IL-10 gene that could promote P/I-activated transcription in Th2 cells. Two strong DNase I-hypersensitive sites (DHSSs) were identified in the IL-10 gene in mouse T cells, and conserved noncoding sequences (CNSs) between the mouse and human IL-10 genes were also identified. One IL-10 DHSS maps within or next to a highly conserved CNS region, CNS-3. The CNS-3 region contains an AP-1 site that binds JunB and c-Jun proteins specifically in Th2 cells and not in Th1 cells. The CNS-3 element activates transcription from the IL-10 promoter after P/I stimulation and is responsive to c-Jun and JunB. Retroviral mediated-expression of either c-Jun or JumB in primary T cells led to a large increase in IL-10 expression, and inhibition of AP-1 activity by a dominant negative form of c-Jun in primary T cells strongly repressed IL-10 expression. IFN-gamma was relatively unaffected by modulations in AP-1 activity. These data indicate that we have identified a novel regulatory element that can specifically activate transcription of the IL-10 gene in Th2 cells via the AP-1/jun pathway.
引用
收藏
页码:2098 / 2105
页数:8
相关论文
共 30 条
  • [1] Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo
    Agarwal, S
    Avni, O
    Rao, A
    [J]. IMMUNITY, 2000, 12 (06) : 643 - 652
  • [2] A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages
    Brightbill, HD
    Plevy, SE
    Modlin, RL
    Smale, ST
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (04) : 1940 - 1951
  • [3] Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO
  • [4] 2-G
  • [5] Chen HJ, 1997, J IMMUNOL, V158, P5112
  • [6] DE WMR, 1991, J EXP MED, V174, P1209
  • [7] DELPRETE G, 1993, J IMMUNOL, V150, P353
  • [8] T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6
    Dent, AL
    Hu-Li, J
    Paul, WE
    Staudt, LM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) : 13823 - 13828
  • [9] AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activin
    Dong, ZG
    Xu, RH
    Kim, JB
    Zhan, SN
    Ma, WY
    Colburn, NH
    Kung, HF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) : 9942 - 9946
  • [10] ENK AH, 1992, J IMMUNOL, V149, P92